30
Participants
Start Date
September 16, 2024
Primary Completion Date
December 12, 2024
Study Completion Date
December 12, 2024
CRYONOVE (EC14_4osc)
The prototype is a variant version from that of a CE marked MD already commercialized (Cryobeauty mains, Cryobeauty Pharma SAS, France) which produces a cryogenic spray sequence (EC14). The prototype is intended to treat pigmented spots of the face (PIH spots and senile and solar lentigos).
CRYONOVE (EC05osc)
The prototype is a variant version from that of a CE marked MD already commercialized (Cryobeauty mains, Cryobeauty Pharma SAS, France) which produces a cryogenic spray sequence (EC05). The prototype is intended to treat pigmented spots of the face (PIH spots and senile and solar lentigos).
SMU - Photobiology Laboratory, Sefako Makgatho Health Sciences University, Pretoria
Lead Sponsor
Collaborators (1)
Dermatech
INDUSTRY
Cryonove Pharma
INDUSTRY